PCI Clinical Services has partnered with Suvoda LLC to leverage Suvoda’s IRT/IWRS technology for subject randomization and trial supply management and to integrate PCI’s packaging and logistics services for clinical trial supplies.
 
PCI customers will have access to Suvoda’s IRT system, which offers a configurable system with the flexibility of a custom-built solution for more rapid deployment and functionality.
 
PCI will also integrate the Suvoda IRT system into its own clinical supply network technologies, providing real-time customized access for various facets of investigational studies, including trial data and visibility across the global supply chain.
 
Suvoda’s IRT system enables the services team to select modules from a central library, configure them for a specific study, and create new modules to meet unique, study-specific needs. The IRT system also integrates into PCI’s own supply network for packaging and labeling services, global storage and distribution, as well as returns management including reconciliation and certified destruction of supplies.
 
Bob Misher, senior vice president for PCI Clinical Services, said, “Our partnership with Suvoda will enable sponsors to leverage the combined power of our respective expertise in a seamless and efficient manner, working collaboratively to deliver an outstanding user experience and ultimately help enable more successful outcomes for their clinical studies through a comprehensive technology and supply solution.”
   
Additionally, PCI has recently expanded its European center of excellence for clinical trial services in Bridgend, UK, as well as its manufacturing center of excellence in Tredegar, UK. The Bridgend location now features extensive temperature controlled storage, and the Tredegar manufacturing site expansion includes investment in additional Xcelodose drug-in-capsule technologies for early phase trials, including fully contained Xcelodose technology for potent compound development.